7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
      
    		                                         
      cash flows from operating activities:
    		                                         
      net income
    		27,771,000 78,755,000 72,945,000 -11,790,000 131,093,000 62,073,000 131,066,000 103,380,000 131,957,000 94,131,000 -2,807,000 -119,185,000 61,232,000 43,058,000 42,962,000 -40,215,000 -13,415,000 -26,657,000 9,008,000 -3,412,000 -6,386,000 -7,012,000 3,337,000 10,450,000 4,856,000 6,412,000 9,949,000 13,293,000 9,269,000 9,745,000 8,211,000 97,126,000 8,526,000 13,595,000 4,138,000 4,869,000 4,220,000 7,350,000 10,323,000 3,916,000 5,386,000 
      adjustments to reconcile net income to net cash flows from operating activities:
    		                                         
      depreciation, amortization and accretion
    		20,408,000 13,231,000 13,626,000 17,285,000 17,075,000 14,819,000 15,445,000 15,015,000 14,653,000 15,760,000 14,615,000 11,881,000 12,155,000 12,107,000 11,786,000 12,200,000 12,339,000 9,626,000 8,123,000 8,394,000 8,531,000 4,032,000 3,732,000 3,539,000 3,263,000 3,254,000 3,323,000 3,385,000 3,455,000 3,493,000 3,596,000 4,212,000 3,748,000 5,111,000 6,160,000    4,586,000   
      adjustment to the fair value of asset retirement obligation
    		0 0 -4,727,000                                       
      amortization of debt-related costs
    		1,113,000                                         
      change in fair value of contingent assets and liabilities
    		                                         
      inventory adjustments
    		1,933,000 2,314,000 -1,378,000                                       
      stock-based compensation
    		24,501,000 22,321,000 21,198,000 22,164,000 20,366,000 18,479,000 15,384,000 14,172,000 13,976,000 12,692,000 9,667,000 8,124,000 8,103,000 7,412,000 5,623,000 4,162,000 3,867,000 4,588,000 3,317,000 3,623,000 3,992,000 3,385,000 3,075,000 2,991,000 3,423,000 3,358,000 2,720,000 2,299,000 2,407,000 2,216,000 1,796,000 2,164,000 1,657,000 1,162,000 945,000   585,000 407,000 478,000 591,000 
      gain on disposal of assets
    		   -2,161,000 0 0 -6,254,000                                   
      unrealized gain on investment in equity securities
    		-1,160,000 -14,573,000 14,862,000  -37,325,000 22,537,000 -60,704,000                                   
      charges incurred pursuant to acquired in-process research and development
    		0 0 5,413,000                                       
      deferred taxes
    		28,956,000 -6,928,000 1,351,000 -25,627,000 3,227,000 -18,889,000 11,260,000 2,017,000 -18,033,000 -3,753,000 -35,863,000 -62,477,000 7,863,000 -7,582,000 14,180,000 3,409,000 -1,657,000 -1,896,000 4,581,000 -553,000 -1,848,000 -400,000 1,467,000 5,935,000 1,403,000 646,000 1,741,000 -1,458,000 2,681,000 1,616,000 2,923,000           
      long-term income tax payable and other long-term liabilities
    		-2,751,000 -642,000 639,000 2,617,000 1,031,000 1,149,000 439,000 -359,000 -4,130,000 1,263,000 123,000 -11,939,000 -1,692,000 375,000 779,000 -4,295,000 -4,764,000 419,000 728,000 714,000 705,000 704,000 705,000 -14,269,000 -923,000 1,018,000 1,018,000 822,000 880,000 663,000 854,000           
      other
    		2,259,000 2,441,000 822,000 5,022,000 2,590,000 2,886,000 1,696,000 1,737,000 1,383,000 510,000 1,225,000 871,000 1,016,000 1,343,000 829,000 788,000 627,000 442,000 655,000 706,000 411,000 -44,000 452,000 193,000 239,000 -4,000 -6,000 398,000 655,000 392,000 -46,000 -355,000 623,000 138,000 643,000 684,000 327,000 -395,000 513,000 -704,000 1,128,000 
      changes in operating assets and liabilities, excluding impact of acquisitions:
    		                                         
      accounts receivable
    		12,830,000 -2,288,000 -26,363,000 7,202,000 43,141,000 -32,588,000 -55,440,000 -25,593,000 -3,966,000 -14,397,000 -24,681,000 -16,429,000 -11,037,000 -15,839,000 -85,155,000 -25,381,000 -9,272,000 3,897,000 -2,346,000 -6,759,000 -2,790,000 3,837,000 -1,750,000 -2,922,000 4,833,000 -715,000 -1,040,000 3,220,000 -2,982,000 3,593,000 -7,816,000 1,202,000 1,759,000 -3,233,000 -3,135,000 -2,130,000 3,080,000 625,000 -2,634,000 -804,000 -3,468,000 
      inventory
    		-915,000 -5,688,000 278,000 4,431,000 874,000 519,000 -8,494,000 -10,225,000 -6,740,000 -12,131,000 -7,124,000 -2,842,000 -2,653,000 -379,000 -1,634,000 -2,924,000 -2,513,000 -2,001,000 3,889,000 1,134,000 -2,816,000 -4,679,000 -2,098,000 1,266,000 1,093,000 -830,000 465,000 1,142,000 -3,118,000 -135,000 -6,579,000 -3,259,000 -2,129,000 -1,805,000 -2,427,000 -1,968,000 -2,183,000 829,000 -304,000 -168,000 -1,967,000 
      other current and noncurrent assets
    		-4,428,000                                         
      accounts payable
    		20,108,000 4,383,000 4,982,000 -9,955,000 -5,722,000 10,335,000 -3,462,000 5,039,000 -2,036,000 7,439,000 6,747,000 -8,108,000 9,270,000 -2,367,000 1,506,000 649,000 -1,112,000 1,778,000 4,110,000 -7,986,000 7,214,000 -2,539,000 -913,000 1,779,000 -1,427,000 1,423,000 1,458,000 -5,086,000 5,100,000 -5,060,000 2,160,000 874,000 -1,037,000 -433,000 1,200,000 3,016,000 1,210,000 -596,000 2,070,000 1,085,000 -2,873,000 
      accrued expenses and other current and noncurrent liabilities
    		-26,313,000 -5,947,000 3,328,000                                       
      net cash from operating activities
    		105,294,000 87,106,000 107,563,000 157,730,000 175,062,000 84,720,000 127,238,000 112,287,000 116,739,000 -32,266,000 108,500,000 105,352,000 93,568,000 72,597,000 10,264,000 13,889,000 4,340,000 25,869,000 9,818,000 569,000 8,575,000 -2,156,000 9,408,000 22,421,000 26,442,000 21,053,000 10,468,000 17,306,000 24,277,000 20,276,000 -666,000 13,086,000 15,600,000 20,567,000 5,524,000       
      cash flows from investing activities:
    		                                         
      capital expenditures
    		-10,622,000 -7,961,000 -8,718,000 -16,369,000 -15,808,000 -11,175,000 -8,273,000 -12,069,000 -14,621,000 -10,697,000 -9,168,000 -4,724,000 -6,090,000 -4,343,000 -3,190,000 -4,544,000 -2,420,000 -2,656,000 -2,520,000 -3,785,000 -3,736,000 -2,255,000 -2,698,000 -4,741,000 -3,336,000 -3,434,000 -10,550,000 -7,366,000 -5,005,000 -5,626,000 -2,135,000 -5,954,000 -3,288,000 -3,402,000 -4,899,000 -2,422,000 -2,588,000 -736,000 -1,652,000 -4,732,000 -2,307,000 
      free cash flows
    		94,672,000 79,145,000 98,845,000 141,361,000 159,254,000 73,545,000 118,965,000 100,218,000 102,118,000 -42,963,000 99,332,000 100,628,000 87,478,000 68,254,000 7,074,000 9,345,000 1,920,000 23,213,000 7,298,000 -3,216,000 4,839,000 -4,411,000 6,710,000 17,680,000 23,106,000 17,619,000 -82,000 9,940,000 19,272,000 14,650,000 -2,801,000 7,132,000 12,312,000 17,165,000 625,000       
      acquisition of in-process research and development
    		0                                         
      proceeds from sale of assets
    		   9,767,000 0 0 8,000,000 0    0 0 0 1,800,000 0 0 0 15,823,000         0 0 0 1,000,000   899,000 335,000   0 9,000,000   
      acquisition of assets
    		   0 -47,000,000   0 0 -10,000,000 -35,345,000                               
      acquisition of evergreen, net of cash acquired
    		165,000                                         
      acquisition of life molecular, net of cash acquired
    		                                         
      purchases of investment in equity securities
    		0 0 -5,000,000 0 -4,990,000 0 -78,256,000                                   
      acquisition of exclusive license option
    		   0 0 0 -28,000,000                                   
      net cash from investing activities
    		-319,468,000 -232,472,000 -63,718,000 -6,602,000 -67,798,000 -45,086,000 -106,529,000 -12,069,000 83,218,000 -20,697,000 -44,513,000 -264,724,000 -6,090,000 -4,343,000 -1,390,000 -4,544,000 -2,420,000   -3,785,000 -3,736,000 5,307,000 -2,698,000 -4,741,000 -3,336,000 -3,434,000 -10,550,000 -7,366,000 -5,005,000 -5,626,000 -1,135,000 -5,954,000 -3,288,000 -2,503,000 -4,564,000       
      cash flows from financing activities:
    		                                         
      payments of long-term debt and other borrowings
    		-292,000                                         
      proceeds from stock option exercises
    		142,000 2,445,000 3,886,000 -494,000 1,289,000 1,549,000 934,000 354,000 273,000 1,347,000 1,842,000 -1,000 758,000 1,423,000 5,357,000 679,000 530,000 2,043,000 2,043,000 0 27,000   0 729,000 120,000 324,000 0 12,000 626,000 514,000 2,037,000 132,000 446,000 632,000 170,000      
      proceeds from employee stock purchase plan
    		1,743,000                                         
      payments for minimum statutory tax withholding related to net share settlement of equity awards
    		-759,000 -795,000 -23,686,000 -892,000 -1,299,000 -1,006,000 -19,418,000 -773,000 -1,000,000 -1,467,000 -11,154,000 -588,000 -843,000 -824,000 -5,504,000 -187,000 -67,000 -193,000 -1,599,000 -47,000 -50,000 -485,000 -1,547,000 -44,000 -346,000 -944,000 -1,120,000 -218,000 -736,000 -1,723,000 -709,000 -172,000 -1,124,000 -1,202,000 -355,000       
      repurchase of common stock
    		-100,000,000                                         
      net cash from financing activities
    		-99,166,000 -98,413,000 -18,219,000 -103,659,000 1,869,000 99,000 -16,845,000 -450,000 108,000 -4,051,000 -8,669,000 317,840,000 -1,959,000 -2,011,000 -2,179,000 -2,100,000 -1,726,000 -715,000 -34,791,000 -4,373,000 -7,270,000 -6,486,000 -3,732,000 -2,823,000 -1,900,000 -72,927,000 -1,231,000 -934,000 -1,217,000 -1,813,000 -704,000 1,150,000 -1,519,000 -1,827,000 -11,254,000       
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-218,000                                         
      net increase in cash, cash equivalents and restricted cash
    		-313,558,000 -242,952,000 25,728,000  109,380,000 38,750,000 4,634,000  200,065,000 -56,777,000 55,220,000  85,272,000 66,073,000 6,846,000  -25,000 22,639,000 -11,691,000                       
      cash, cash equivalents and restricted cash, beginning of period
    		0 0 914,486,000  0 0 715,285,000  0 0 417,241,000  0 0 100,651,000  0 0 82,694,000  0                     
      cash, cash equivalents and restricted cash, end of period
    		-313,558,000 -242,952,000 940,214,000  109,380,000 38,750,000 719,919,000  200,065,000 -56,777,000 472,461,000  85,272,000 66,073,000 107,497,000  -25,000 22,639,000 71,003,000  -2,315,000                     
      amortization of debt related costs
    		  1,115,000 1,079,000 1,072,000 1,072,000 1,073,000 1,073,000 1,072,000 1,073,000 1,082,000 512,000 246,000 245,000 246,000 246,000 245,000 246,000 -61,000 -80,000 -139,000 169,000 169,000 169,000 170,000 319,000 320,000 320,000 320,000 319,000 320,000 330,000 335,000         
      changes in assets and liabilities which provided (used) cash:
    		                                         
      other current assets
    		  -528,000 3,105,000 -1,831,000 -857,000 4,023,000 -4,914,000 11,756,000 -11,739,000 2,479,000 -2,754,000 -430,000 848,000 -104,000 -2,071,000 -173,000 2,707,000 -536,000 378,000 -179,000 593,000 1,149,000 -2,215,000 -78,000 1,034,000 -1,152,000 -612,000 532,000 422,000 -1,003,000 -442,000 303,000 1,001,000 -1,250,000 877,000 -1,425,000 1,435,000 -1,042,000 943,000 -707,000 
      deposit for acquisition of a business
    		  -50,000,000                                       
      payments on long-term debt and other borrowings
    		  -402,000 58,000 252,000 -444,000 -184,000 -32,000 -157,000 -231,000 -297,000 -167,494,000 -2,672,000 -2,610,000 -2,609,000 -2,591,000 -2,620,000 -2,565,000 -35,572,000 -4,325,000 -4,134,000 -4,481,000 -2,551,000 -2,555,000 -2,574,000 -269,530,000 -717,000               
      proceeds from issuance of common stock
    		  1,983,000 0 1,627,000 0 1,823,000 0 993,000 0 940,000 0 798,000 0 577,000 -1,000 431,000 0 337,000 0 317,000 0 366,000 0 291,000 0 282,000 0 222,000 0 206,000 0          
      effect of foreign exchange rates on cash, cash equivalents and restricted cash
    		  102,000  247,000 -983,000 770,000  0 237,000 -98,000  -247,000 -170,000 151,000  -219,000 141,000 -21,000  116,000                     
      operating activities
    		                                         
      impairment of long-lived assets
    		       0 0 5,998,000 132,052,000     189,000    2,660,000 0 0 7,275,000                   
      asset retirement obligation acceleration
    		           -949,000 729,000                             
      gain on interest rate swap termination
    		                                         
      changes in fair value of contingent assets and liabilities
    		   -1,294,000 -1,505,000   200,000 -500,000 -7,575,000 -1,400,000 9,300,000 -1,500,000 8,500,000 18,400,000 43,900,000 2,600,000 25,600,000 300,000 -2,800,000                      
      charges incurred in connection with acquired ipr&d
    		   0 0 38,000,000 28,000,000                                   
      loss on extinguishment of debt
    		                       0 0         0 2,161,000     0 0 
      benefit from excess and obsolete inventory
    		     -832,000 2,757,000 2,663,000 2,072,000 2,499,000 680,000 2,165,000 1,795,000 666,000 2,519,000 1,740,000 278,000 644,000 1,395,000 495,000 339,000 1,082,000 449,000 152,000 722,000 466,000 511,000 405,000 511,000 739,000 1,220,000 213,000 272,000 445,000 285,000 360,000 164,000 321,000 497,000 286,000 606,000 
      gain on sale of relistor licensed intangible asset associated with net sales royalties
    		                                         
      unrealized loss on investment in equity securities
    		                                         
      long-term indemnification receivable
    		       0 4,256,000 -231,000 -96,000                               
      other long-term assets
    		           0 0 0 -533,000                           
      accrued expenses and other liabilities
    		   28,238,000 1,810,000 -33,730,000 50,449,000 8,082,000 22,808,000 -123,805,000 11,801,000 33,201,000 7,011,000 24,400,000 -1,037,000 12,204,000 3,927,000 6,634,000 -6,620,000 2,574,000 1,287,000 -733,000 -7,289,000 3,837,000 8,056,000 2,031,000 -7,847,000 -220,000 5,137,000 2,989,000 -5,656,000 2,288,000 1,543,000 3,890,000 -3,196,000 -1,155,000 4,479,000 2,591,000 -4,573,000 11,000 2,718,000 
      investing activities
    		                                         
      financing activities
    		                                         
      debt issuance costs
    		                                         
      proceeds from issuance of long-term debt
    		                       0 0       0 0 0 274,313,000     0 0 
      contingent value rights settlement
    		       0 0                                 
      deferred financing costs
    		                   -1,000 2,000   -224,000 0       0 0 -357,000 -1,219,000 0 0   -7,000 -982,000 
      proceeds from interest rate swap termination
    		                                         
      effect of foreign exchange rates on cash and cash equivalents
    		                      -184,000 0 -29,000 132,000 -27,000 -189,000 65,000 -112,000 -46,000 -69,000 130,000 35,000 -2,000 -181,000      
      net increase in cash and cash equivalents and restricted cash
    		                                         
      cash and cash equivalents and restricted cash, beginning of year
    		                                         
      cash and cash equivalents and restricted cash, end of year
    		                                         
      gain on extinguishment of debt
    		                0 0 -889,000                       
      (decreases) increases in cash from operating assets and liabilities:
    		                                         
      (gain) loss on disposal of assets
    		                                         
      increases (decreases) in cash from operating assets and liabilities:
    		                                         
      lending on bridge loan
    		                   0 0                     
      cash acquired in acquisition of business
    		                   0 0                     
      equity issuance costs
    		                   0 -3,432,000                     
      gain on sale of assets
    		                0 0 -15,263,000                   -117,000 -5,828,000   
      long-term income tax receivable
    		            1,461,000 -397,000 -396,000  3,823,000 -158,000 -573,000 -554,000 -555,000 -555,000 -554,000 11,477,000 762,000 -802,000 -802,000 -635,000 -692,000 -687,000 -841,000           
      aro acceleration
    		              293,000                           
      (gain) loss on extinguishment of debt
    		                                         
      net cash from provided by investing activities
    		                  13,303,000                       
      loss on disposal of assets
    		                                         
      benefit from bad debt
    		                    9,000 4,000 202,000 39,000 50,000 247,000 -190,000 33,000 122,000 -29,000 195,000           
      net decrease in cash, cash equivalents and restricted cash
    		                    -2,315,000                     
      net increase in cash and cash equivalents
    		                      2,794,000 14,857,000 21,177,000   8,817,000 18,120,000   8,213,000 10,923,000 16,272,000 -10,296,000       
      cash and cash equivalents, beginning of period
    		                      92,919,000  0 0 113,401,000  0 0 76,290,000  0 0 51,178,000  0 0 28,596,000  0 
      cash and cash equivalents, end of period
    		                      95,713,000  21,177,000 -55,176,000 112,061,000  18,120,000 12,725,000 73,739,000  10,923,000 16,272,000 40,882,000  -1,656,000 15,971,000 38,880,000  -278,000 
      loss on impairment of land
    		                                         
      payments for public offering costs
    		                                         
      cash and cash equivalents, beginning of year
    		                                         
      cash and cash equivalents, end of year
    		                                         
      net decrease in cash and cash equivalents
    		                          -1,340,000    -2,551,000           
      gain on sales of assets
    		                                   120,000      
      loss on extinguishment of debt and debt retirement costs
    		                               281,000          
      payments on long-term debt
    		                           -716,000 -715,000 -716,000 -715,000 -715,000 -714,000 -714,000 -284,551,000   -928,000 -933,000 -931,000  
      write-off of deferred offering and financing costs
    		                                         
      income taxes
    		                                      -235,000   
      payments on senior notes
    		                                       0  
      payment for call premium on senior notes
    		                                       0 0 
      net movement in line of credit
    		                                         
      proceeds from sales of assets
    		                                         
      redemption of certificate of deposit—restricted
    		                                         
      debt retirement costs
    		                                   481,000      
      supplemental disclosure of cash flow information
    		                                         
      cash paid during the period for:
    		                                         
      interest
    		                                         
      income taxes, net of refunds of 82, 363 and 317, respectively
    		                                         
      schedule of non-cash investing and financing activities
    		                                         
      additions of property, plant & equipment included in liabilities
    		                                         
      receivable in connection with sale of australian subsidiary
    		                                         
      adjustments to reconcile net income to cash flows from operating activities:
    		                                         
      depreciation and amortization
    		                                    3,842,000    4,075,000 
      stock-based compensation expense
    		                                         
      changes in operating assets and liabilities:
    		                                         
      cash from operating activities
    		                                    15,446,000 17,635,000 3,780,000 12,626,000 5,417,000 
      redemption of certificate of deposit – restricted
    		                                         
      cash from investing activities
    		                                    -1,047,000 -736,000 7,422,000 -4,732,000 -2,307,000 
      proceeds from issuance of common stock in public offering
    		                                         
      payments for offering costs
    		                                       0 0 
      principal payments on long-term debt
    		                                         
      principal payments on senior notes
    		                                         
      repayments of amounts borrowed under revolving line of credit
    		                                         
      payments of minimum statutory tax withholdings on net share settlements of equity awards
    		                                         
      cash from financing activities
    		                                    -16,086,000 -928,000 -944,000 -1,042,000 -3,014,000 
      increase in cash and cash equivalents
    		                                    -1,656,000 15,971,000 10,284,000 6,674,000 -278,000 
      cash flows from operating activities
    		                                         
      adjustments to reconcile net income to cash flow from operating activities
    		                                         
      increase in cash from operating assets and liabilities
    		                                         
      cash flows from investing activities
    		                                         
      redemption of certificate of deposit - restricted
    		                                     0 74,000   
      cash flows from financing activities
    		                                         
      proceeds from issuance of common stock in initial public offering
    		                                       0 0 
      payments for initial public offering costs
    		                                         
      payments on line of credit
    		                                       0 0 
      payments on note payable
    		                                         
      effect of foreign exchange rate on cash
    		                                     0 26,000 -178,000 -374,000 
      interest paid
    		                                     6,368,000 6,422,000 6,513,000 6,534,000 
      income taxes paid
    		                                       93,000 8,000 
      income taxes paid/(refunded)
    		                                      199,000   
      cash flow from operating activities
    		                                         
      impairment of land
    		                                         
      impairment of intangible assets
    		                                         
      proceeds from sale of property, plant and equipment
    		                                         
      proceeds from line of credit
    		                                         
      proceeds from issuance of common stock, other
    		                                         
      payments for common stock repurchase
    		                                         
      payments for tax withholding related to net share settlement of equity awards
    		                                         
      payments of dividend
    		                                         
      noncash investing and financing activities
    		                                         
      property, plant and equipment included in accounts payable and accrued expenses and other liabilities
    		                                       185,000 -636,000 
      deferred offering cost included in accounts payable and accrued expenses and other liabilities
    		                                         
      deferred income taxes
    		                                        -72,000 
      write-off of deferred financing costs
    		                                         
      initial public offering costs
    		                                        -1,003,000 
      payment for tax withholding related to net share settlement of equity awards
    		                                         
      initial public offering costs included in accrued expenses and other liabilities
    		                                         
      payments of senior notes
    		                                         
      initial public offering costs included in accounts payable and accrued expenses and other liabilities
    		                                         
      deferred financing costs included in accrued expenses and other liabilities
    		                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.